Oklahoma Osteopathic Association’s Virtual 2021 Winter CME Seminar “Go Fast” – Saturday Lectures – Jason L. Beaman, Glennda D, Donald J. Kyle

Jason L. Beaman, DO, MS, MPH, FAPA Related seminars and products: 2

Jason L. Beaman, DO, MS, MPH, FAPA, graduated medical school from Oklahoma State University Center for Health Sciences in 2007. He then completed two simultaneous residencies in Psychiatry and Family Medicine. After residency, Dr. Beaman completed a fellowship in Forensic Psychiatry at Case Western Reserve University in Cleveland, Ohio. He holds board
certification in Family Medicine, Psychiatry and Forensic Psychiatry. After Fellowship Dr. Beaman completed a Master’s Degree in Pharmacology with an emphasis in Forensics at the University of Florida. He recently obtained a Master’s in Public Health from Johns Hopkins University. Dr. Beaman currently serves as the Chair of Psychiatry and Behavioral Sciences at Oklahoma State
University Center for Health Sciences. He provides clinical psychiatric consults at OSU Medical Center and performs private forensic evaluations and consulting.

Glennda D, Tiller, DO, MEd Related seminars and products: 1

Glennda D. Tiller, DO, MEd, is from Oklahoma City, OK. She was born and raised there graduating from Putnam City North High School. She then attended Southwestern Oklahoma State University where she received a Bachelor of Science in Biological Sciences and a Master of Education in Health Science and Microbiology. She then went on achieve her Doctor of Osteopathic Medicine degree from Oklahoma State University College of Osteopathic Medicine, graduating in 2017. While at OSU-COM she was an OMM teaching assistant, Stress management leader, President of the ACOP student club and secretary of the AMWA student club. After graduation she began her Family Medicine Residency at OSU in the OMECO program which she completed in June of 2020. In residency, she was involved in the ACOFP Task Force on Teen Sexual Health, was a resident member of the OMECO resident council, went on to be the resident chair of the council and was one of the resident representatives for the OSU/OMECO GMEC. During her PGY-3 year, she was chief resident of the OMECO program with the primary responsibility for planning and coordinating the OSU and OMECO Family Medicine academic programming for the 2019-2020 academic year. She then went on to join the faculty of the OSU Family Medicine program as a Clinical Assistant Professor of Family Medicine in July 2020. She is married to her wonderful wife, Autumn, and together they have one 3-year-old son Dev. In her free time, she enjoys spending time with her family, grilling and reading historical fiction.

Donald J. Kyle, PhD Related seminars and products: 1

VP Science & Academic Outreach

Oklahoma State University College of Osteopathic Medicine

Donald J. Kyle, PhD received a BS degree in chemistry from Colorado State University in 1982, then earned a Ph.D. in synthetic organic chemistry from Texas Tech University in 1986. He has worked in the pharmaceutical industry for 34 years. His first industrial position was at Nova Pharmaceutical Corporation where he designed and synthesized experimental molecules for treating various CNS diseases including pain and participated in the development of high throughput screening and combinatorial chemistry for drug discovery. He pioneered structure-based design approaches to novel bradykinin receptor antagonists for pain and asthma, and developed computational tools aimed at the elucidation of protein structure for drug design.

After holding various scientific leadership positions at several companies, Dr. Kyle joined Purdue Pharma in 1998 to create a new pain research department and pipeline of potential new pain products that did not produce the same unwanted effects as opioids, NSAIDS, or COX-2 inhibitors. Between 2005 and 2012 his team delivered 5 FDA-approved INDs (Investigational New Drug Applications), several of which proceeded into multiple phase 2 trials. During his professional tenure, he has investigated many pain-related cellular mechanisms and has conducted extensive research in the opioid field. For the latter, he worked more than 15 years searching for mechanistic pathways to separate analgesia from euphoria and respiratory depression. In 2016 he was an invited scientific member of joint academia, industry, NIH, brainstorming meetings and working groups tasked to outline science-led solutions to the opioid crisis (ultimately becoming the HEAL initiative).

His scientific accomplishments are reflected in nearly 200 scientific publications, review papers, books and chapters, as well as 95 issued US patents across a wide range of technologies, molecules, therapeutic areas, and commercial products. He is a reviewer and editorial advisory board member for several peer-reviewed journals and has held several adjunct faculty appointments. He is currently an executive director at the National Center for Wellness and Recovery at Oklahoma State University.